Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma

Tezepelumab and Mucus Plugs in Patients with AsthmaMucus plugs in airways of asthma patients are associated with airway obstruction and the activity of inflammatory cytokines. This article reports prespecified and post hoc analyses of the effect of tezepelumab treatment on mucus plugs identified by computed tomography imaging in patients with moderate-to-severe asthma. At baseline, mucus plug scores correlated positively with levels of inflammatory biomarkers and negatively with lung function measures. Patients treated with tezepelumab had resolution of more mucus plugs than patients taking placebo.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:2

Enthalten in:

NEJM evidence - 2(2023), 10 vom: 01. Okt., Seite EVIDoa2300135

Sprache:

Englisch

Beteiligte Personen:

Nordenmark, Lars H [VerfasserIn]
Hellqvist, Åsa [VerfasserIn]
Emson, Claire [VerfasserIn]
Diver, Sarah [VerfasserIn]
Porsbjerg, Celeste [VerfasserIn]
Griffiths, Janet M [VerfasserIn]
Newell, John D [VerfasserIn]
Peterson, Samuel [VerfasserIn]
Pawlikowska, Beata [VerfasserIn]
Parnes, Jane R [VerfasserIn]
Megally, Ayman [VerfasserIn]
Colice, Gene [VerfasserIn]
Brightling, Christopher E [VerfasserIn]

Links:

Volltext

Themen:

Antibodies, Monoclonal, Humanized
Clinical Trial
Journal Article
RJ1IW3B4QX
Tezepelumab

Anmerkungen:

Date Completed 10.02.2024

Date Revised 10.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1056/EVIDoa2300135

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368095770